Lupin, Cipla and Aurobindo: Axis Securities advises to buy these 3 pharma firms after Q1 earnings – key reasons
HDFC Securities prefers economy-facing and value sectors after Q1 earnings; a look at top changes in its model portfolio
Earnings Review: These 4 Nifty50 stocks delivered over 95% growth in net profit in Q1